PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Coloplast A/S (CBHD.DE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINDK0060448595
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap€26.03B
EPS€2.99
PE Ratio38.75
PEG Ratio3.46
Revenue (TTM)€25.00B
Gross Profit (TTM)€15.53B
EBITDA (TTM)€7.66B
Year Range€78.34 - €130.95

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Coloplast A/S

Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Coloplast A/S, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%400.00%600.00%800.00%1,000.00%1,200.00%December2024FebruaryMarchAprilMay
953.26%
208.29%
CBHD.DE (Coloplast A/S)
Benchmark (^GSPC)

S&P 500

Returns By Period

Coloplast A/S had a return of 8.27% year-to-date (YTD) and 5.08% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date8.27%6.17%
1 month-8.72%-2.72%
6 months28.83%17.29%
1 year5.08%23.80%
5 years (annualized)22.88%11.47%
10 years (annualized)N/A10.41%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20242.93%13.03%2.44%-8.39%
2023-1.70%10.21%13.23%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CBHD.DE is 53, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of CBHD.DE is 5353
Coloplast A/S(CBHD.DE)
The Sharpe Ratio Rank of CBHD.DE is 5454Sharpe Ratio Rank
The Sortino Ratio Rank of CBHD.DE is 5151Sortino Ratio Rank
The Omega Ratio Rank of CBHD.DE is 4848Omega Ratio Rank
The Calmar Ratio Rank of CBHD.DE is 5858Calmar Ratio Rank
The Martin Ratio Rank of CBHD.DE is 5353Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Coloplast A/S (CBHD.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CBHD.DE
Sharpe ratio
The chart of Sharpe ratio for CBHD.DE, currently valued at 0.16, compared to the broader market-2.00-1.000.001.002.003.004.000.16
Sortino ratio
The chart of Sortino ratio for CBHD.DE, currently valued at 0.54, compared to the broader market-4.00-2.000.002.004.006.000.54
Omega ratio
The chart of Omega ratio for CBHD.DE, currently valued at 1.06, compared to the broader market0.501.001.501.06
Calmar ratio
The chart of Calmar ratio for CBHD.DE, currently valued at 0.20, compared to the broader market0.002.004.006.000.20
Martin ratio
The chart of Martin ratio for CBHD.DE, currently valued at 0.40, compared to the broader market-10.000.0010.0020.0030.000.40
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.97, compared to the broader market-2.00-1.000.001.002.003.004.001.97
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.84, compared to the broader market-4.00-2.000.002.004.006.002.84
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.34, compared to the broader market0.501.001.501.34
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.002.004.006.001.50
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market-10.000.0010.0020.0030.007.61

Sharpe Ratio

The current Coloplast A/S Sharpe ratio is 0.16. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Coloplast A/S with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00December2024FebruaryMarchAprilMay
0.16
2.33
CBHD.DE (Coloplast A/S)
Benchmark (^GSPC)

Dividends

Dividend History

Coloplast A/S granted a 18.65% dividend yield in the last twelve months. The annual payout for that period amounted to €21.00 per share.


PeriodTTM2023202220212020201920182017201620152014
Dividend€21.00€21.00€20.00€19.00€18.00€17.00€16.00€15.00€13.50€12.50€7.50

Dividend yield

18.65%20.19%18.21%12.16%14.22%15.27%19.77%22.52%20.90%16.79%10.64%

Monthly Dividends

The table displays the monthly dividend distributions for Coloplast A/S. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024€0.00€0.00€0.00€0.00
2023€0.00€0.00€0.00€0.00€5.00€0.00€0.00€0.00€0.00€0.00€0.00€16.00
2022€0.00€0.00€0.00€0.00€5.00€0.00€0.00€0.00€0.00€0.00€0.00€15.00
2021€0.00€0.00€0.00€0.00€5.00€0.00€0.00€0.00€0.00€0.00€0.00€14.00
2020€0.00€0.00€0.00€0.00€5.00€0.00€0.00€0.00€0.00€0.00€0.00€13.00
2019€0.00€0.00€0.00€0.00€5.00€0.00€0.00€0.00€0.00€0.00€0.00€12.00
2018€0.00€0.00€0.00€0.00€5.00€0.00€0.00€0.00€0.00€0.00€0.00€11.00
2017€0.00€0.00€0.00€0.00€4.50€0.00€0.00€0.00€0.00€0.00€0.00€10.50
2016€0.00€0.00€0.00€0.00€4.50€0.00€0.00€0.00€0.00€0.00€0.00€9.00
2015€0.00€0.00€0.00€0.00€4.50€0.00€0.00€0.00€0.00€0.00€0.00€8.00
2014€7.50

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%18.7%
Coloplast A/S has a dividend yield of 18.65%, which means its dividend payment is significantly above the market average.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%7.0%
Coloplast A/S has a payout ratio of 6.97%, which is below the market average. This means Coloplast A/S returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-14.01%
-3.27%
CBHD.DE (Coloplast A/S)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Coloplast A/S. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Coloplast A/S was 35.71%, occurring on Jun 17, 2022. Recovery took 377 trading sessions.

The current Coloplast A/S drawdown is 14.01%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-35.71%Dec 29, 2021115Jun 17, 2022377Dec 14, 2023492
-21.95%Jun 2, 2020130Dec 1, 202047Feb 10, 2021177
-20.04%Apr 16, 201557Jul 7, 201586Nov 4, 2015143
-18.55%Aug 16, 201663Nov 14, 201619Dec 9, 201682
-18.09%Feb 16, 202113Mar 5, 202176Jun 30, 202189

Volatility

Volatility Chart

The current Coloplast A/S volatility is 8.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
8.60%
3.72%
CBHD.DE (Coloplast A/S)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Coloplast A/S over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items